News

The use of microplasmin (ocriplasmin; Jetrea, ThromboGenics) was evaluated in the Microplasmin for Children (MIC) trial for use in pediatric patients. The results are forthcoming.

Iridex Corp. has entered into a global distribution and supply agreement with Peregrine Surgical Ltd. to become a worldwide distributor for Peregrine labeled products, and Peregrine Surgical will become part of the Iridex supply chain.

Lorenz E. Zimmerman, MD, the founder of modern ophthalmic pathology, who spent his career studying diseases of the eye, died March 16, 2013 of complications from an infection.

The FDA has approved a new drug application for phenylephrine hydrochloride ophthalmic solution, USP 2.5% and 10% (Paragon BioTeck Inc.) to dilate the pupil.

Playing it safe

Risk-averse behavior creates self-defeating pattern